Spotlight On Hodgkin Lymphoma
We invite you to learn more about:
- Treatment advances for Hodgkin lymphoma
- Side-effect management
- Treatment options for relapsed/refractory patients
- Monitoring for long term and late effects
- The importance of discussing quality of life issues with your healthcare team
Jeremy Abramson, MD
Director, Jon and Jo Ann Hagler Center for Lymphoma
Massachusetts General Hospital Cancer Center
Associate Professor of Medicine
Harvard Medical School
Boston, MA
Program Support
Support for this program is provided by The Leukemia & Lymphoma Society.
Sofia
Sofia
As a five-year survivor of Hodgkin lymphoma (HL), I have come to truly appreciate the value of life's opportunities and the importance of being fully present in every moment. My battle against cancer has shaped me into a determined and compassionate individual, instilling in me a deep sense of empathy for others facing similar challenges.
Lily
Lily
Hello, my name is Lily and I am 14 years old. In November of 2022, I was diagnosed with stage 3 Hodgkin lymphoma (HL). At the beginning, I was completely shocked because there was no sign that anything was wrong with my health. It was the hardest news I’ve ever heard in my life.
Thomas
Thomas
I had bariatric surgery on May 11, 2022. At the time, I weighed just under 600 pounds, and I understood that there was a higher possibility for complications. My three-hour procedure turned into a six-hour procedure, and my overnight stay in the hospital turned into a week.
Olivia
Olivia
I'm officially nine months in remission and just celebrated my first birthday (27!) since finishing chemotherapy treatment. In January 2022, I was diagnosed with stage IVB Hodgkin lymphoma (HL) after taking almost nine months to officially be diagnosed. Unfortunately, delayed diagnoses are often the frustrating truth for many adolescent and young adult cancer patients.